BeStock  
Stocks › Biotechnology › ORKA

Oruka Therapeutics ORKA

US equityMarket cap rank #1788Biotechnology
$95.81 −$1.76 (-1.80%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $95.81 0.00%
Open$95.86
Prev close$97.57
Day range$93.30 – $97.24
Volume1.98M
Market cap$6.50B
P/E (TTM)–
Dividend yield–

ORKA Stock News

Headlines matching Oruka Therapeutics or the ORKA ticker, most recent first.

  • LifeSci Capital Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $175Market news · 9 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $120Market news · 3 Sep 2026 · Direct mention
  • Wedbush Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $165Market news · 24 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Oruka Therapeutics(ORKA.US), With a Forecast Between $120 to $175Market news · 24 Sep 2026 · Direct mention
  • Barclays Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $160Market news · 21 Sep 2026 · Direct mention
  • UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $130Market news · 2 Sep 2026 · Direct mention
  • Analysts Have Conflicting Sentiments on These Healthcare Companies: Fractyl Health, Inc. (GUTS) and Oruka Therapeutics (ORKA)TipRanks · 2 Sep 2026 · Direct mention
  • TD Cowen Maintains Oruka Therapeutics(ORKA.US) With Buy RatingMarket news · 26 Aug 2026 · Direct mention
  • Piper Sandler Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $180Market news · 17 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Oruka Therapeutics(ORKA.US), With a Forecast Between $133 to $180Market news · 12 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Oruka Therapeutics(ORKA.US), With a Forecast Between $151 to $200Market news · 11 Aug 2026 · Direct mention
  • LifeSci Capital Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $125Market news · 1 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), Alto Neuroscience, Inc. (ANRO) and Astrana Health (ASTH)TipRanks · 14 Jul 2026 · Direct mention
  • UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Raises Target Price to $130 PositiveMarket news · 1 Jul 2026 · Direct mention
  • Stifel Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $150Market news · 29 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ORKA.

Sign in to join the discussion.

Scroll to Top